The record index fell 0.66% in half a day, and many stocks in the traditional Chinese medicine plate bucked the market limit

In early trading on Tuesday, A-Shares were weak and fell slightly. On the disk, pharmaceutical commerce, traditional Chinese medicine, logistics, three child concept, phosphorus chemical industry, real estate and other sectors led the increase; Digital currency, hjt battery, pork, semiconductor and components, Hongmeng concept and other sectors led the decline.

As of midday closing, the stock index fell 0.08% to 3590.82. The Shenzhen Component Index fell 0.54% to 14328.60. The gem index fell 0.66% to 3075.41.

Specifically, the traditional Chinese medicine sector strengthened again, Ji Yao Holding Group Co.Ltd(300108) 20cm limit, Guangdong Zhongsheng Pharmaceutical Co.Ltd(002317) , Kpc Pharmaceuticals Inc(600422) , Dong-E-E-Jiao Co.Ltd(000423) , Dali Pharmaceutical Co.Ltd(603963) , and Kunming Longjin Pharmaceutical Co.Ltd(002750) , Guizhou Yibai Pharmaceutical Co.Ltd(600594) followed.

Three child concept stocks were strong, Kidswant Children Products Co.Ltd(301078) , Honz Pharmaceutical Co.Ltd(300086) rose by more than 10%, and Jiangsu Aoyang Health Industry Co.Ltd(002172) , Goldlok Holdings(Guangdong) Co.Ltd(002348) , Chahua Modern Housewares Co.Ltd(603615) , Jinfa Labi Maternity & Baby Articles Co.Ltd(002762) , Zhejiang Shapuaisi Pharmaceutical Co.Ltd(603168) rose by the limit, followed by Shanghai Aiyingshi Co.Ltd(603214) , Winner Medical Co.Ltd(300888) .

In addition, the pharmaceutical business sector strengthened intraday, Shanghai Kaikai Industry Company Limited(600272) 7 connected to the board, Guangxi Liuzhou Pharmaceutical Co.Ltd(603368) , Shanghai No.1 Pharmacy Co.Ltd(600833) limit, Shuyu Civilian Pharmacy Corp.Ltd(301017) , Yunnan Jianzhijia Health-Chain Co.Ltd(605266) , Qingdao Baheal Medical Inc(301015) , Zhejiang Int’L Group Co.Ltd(000411) followed.

In terms of north capital, the half day net outflow of north capital exceeded 500 million yuan, including the inflow of Shanghai Stock connect exceeded 600 million yuan and the outflow of Shenzhen Stock connect exceeded 1.1 billion yuan.

In terms of individual stocks, the current trading limit shares are as follows: Andon Health Co.Ltd(002432) (10.00%), Hubei Radio & Television Information Network Co.Ltd(000665) (10.05%), Macrolink Culturaltainment Development Co.Ltd(000620) (9.85%), Ji Yao Holding Group Co.Ltd(300108) (19.90%), Zhejiang Yatai Pharmaceutical Co.Ltd(002370) (10.06%). The down limit shares are as follows: Anshan Heavy Duty Mining Machinery Co.Ltd(002667) (- 9.99%) and Qingdao Foods Co.Ltd(001219) (- 10.00%).

The top five stocks with turnover rate are: Kidswant Children Products Co.Ltd(301078) , bidding shares, Inner Mongolia Xinhua, Shenzhen Bioeasy Biotechnology Co.Ltd(300942) , Guangdong Sanhe Pile Co.Ltd(003037) , which are 55.673%, 54.028%, 34.843%, 33.007% and 32.634% respectively.

For this year’s A-share market, according to the analysis of Yingda Securities Research Report, 2022 is not a big year, and it is difficult to rise or fall sharply. The shock may be the main tone, the center may rise slightly, and the amplitude will increase slightly. The market does not lack structural opportunities, the style will be more balanced, and there will be opportunities for value and growth. In addition, at present, the valuations of gem and sci-tech innovation board are not low, and the valuation premium of the relative value of scientific and technological growth and blue chip has been obvious. In the short term, we should pay attention to the pullback risk, but the scientific and technological growth representing transformation and upgrading is still the main line in the medium and long term.

Hualong Securities said that this year the market will remain “stable” and the central bank will rise slightly. It is expected that the liquidity of A-share market will be relatively abundant in 2022. Under the condition of policy support, the valuation will be supported and the slow bull in A-share market will continue.

(source: Zhongxin Jingwei)

- Advertisment -